The “Skinny” on Assessment and Utilization of Steatotic Liver Grafts: A Systematic Review

The frequency at which steatotic deceased donor liver grafts are encountered will likely continue to increase. Utilization of liver grafts with moderate‐to‐severe steatosis for liver transplantation (LT) has been previously shown to be associated with increased rates of primary nonfunction and decreased recipient survival. In order to better inform clinical decision making and guide future research, critical evaluation of the literature on donor liver steatosis and posttransplantation outcome is needed. This literature review aims to provide the “skinny” on using deceased donor steatotic livers for LT.

• Publication year

  2019

• Venue

  Liver transplantation

• Publication date

  2019-02-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/lt.25408PMID 30817859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion

  2018cited by this paper
• The first case of ischemia‐free organ transplantation in humans: A proof of concept

  2018cited by this paper
• Ex situ machine perfusion as a tool to recondition steatotic donor livers: Troublesome features of fatty livers and the role of defatting therapies. A systematic review.

  2018cited by this paper
• The first case of ischemia‐free organ transplantation in humans: A proof of concept

  2018cited by this paper
• Impact of donor age in donation after circulatory death liver transplantation: Is the cutoff “60” still of relevance?

  2018cited by this paper
• Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans.

  2017cited by this paper
• Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity‐matched cohort

  2017cited by this paper
• MacSween's Pathology of the Liver

  2017cited by this paper
• Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation.

  2017influential reference
• Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.

  2016cited by this paper
• Excellent outcomes of liver transplantation using severely steatotic grafts from brain‐dead donors

  2016influential reference
• Development of a normothermic extracorporeal liver perfusion system toward improving viability and function of human extended criteria donor livers

  2016cited by this paper
• Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors

  2016cited by this paper
• Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.

  2015influential reference
• Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short

  2015influential reference
• Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review

  2015cited by this paper
• Hypothermic Machine Preservation Facilitates Successful Transplantation of “Orphan” Extended Criteria Donor Livers

  2015cited by this paper
• Liver Transplantation Using Grafts from Donation After Cardiac Death Donors

  2015cited by this paper
• Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver‐to‐spleen attenuation ratio

  2015cited by this paper
• Macrosteatotic and nonmacrosteatotic grafts respond differently to intermittent hepatic inflow occlusion: Comparison of recipient survival

  2015cited by this paper
• Normothermic liver preservation: a new paradigm?

  2015cited by this paper
• Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation.

  2014influential reference
• Expanded criteria donors.

  2014cited by this paper
• Automated image analysis method for detecting and quantifying macrovesicular steatosis in hematoxylin and eosin–stained histology images of human livers

  2014cited by this paper
• The use of guideline images to improve histological estimation of hepatic steatosis

  2014cited by this paper
• Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm

  2013cited by this paper
• Hepatic steatosis estimated microscopically versus digital image analysis

  2013cited by this paper
• Assessment of hepatic steatosis by transplant surgeon and expert pathologist: A prospective, double‐blind evaluation of 201 donor livers

  2013cited by this paper
• Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.

  2012cited by this paper
• Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index

  2012influential reference
• The Use of Fatty Liver Grafts in Modern Allocation Systems: Risk Assessment by the Balance of Risk (BAR) Score

  2012cited by this paper
• Hepatic steatosis is not always a contraindication for cadaveric liver transplantation.

  2011influential reference
• Hepatic Steatosis and Normothermic Perfusion—Preliminary Experiments in a Porcine Model

  2011cited by this paper
• Short- and long-term outcomes after steatotic liver transplantation.

  2010cited by this paper
• Donation after Cardiac Death Liver Transplantation: Predictors of Outcome

  2010cited by this paper
• The biopsied donor liver: Incorporating macrosteatosis into high‐risk donor assessment

  2010influential reference
• Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors

  2010influential reference
• Assessment of Hepatic Steatosis by Expert Pathologists: The End of a Gold Standard

  2009cited by this paper
• Donor livers with steatosis are safe to use in hepatitis C virus–positive recipients

  2009cited by this paper
• Expanding Postmortem Donor Pool Using Steatotic Liver Grafts: A New Look

  2009influential reference
• Efficacy and safety of moderately steatotic donor liver in transplantation.

  2009cited by this paper
• Reversal of graft steatosis after liver transplantation: prospective study.

  2009influential reference
• Steatosis of the graft is a risk factor for posttransplantation biliary complications.

  2009cited by this paper
• Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo.

  2009cited by this paper
• National Organ Retrieval Imaging System: results of the pilot study

  2008cited by this paper
• Effect of graft steatosis on liver function and organ survival after liver transplantation.

  2008influential reference
• Nonalcoholic steatohepatitis in donors for living donor liver transplantation

  2007cited by this paper
• Nonalcoholic steatohepatitis in donors for living donor liver transplantation.

  2007cited by this paper
• Reduced severity of liver ischemia/reperfusion injury following hepatic resection in humans is associated with enhanced intrahepatic expression of Th2 cytokines.

  2006cited by this paper
• Assignment of steatotic livers by the Mayo model for end‐stage liver disease

  2005influential reference
• Impact of steatotic grafts on initial function and prognosis after liver transplantation.

  2004influential reference
• Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation

  2003influential reference
• Marginal grafts: finding the correct treatment for fatty livers

  2003cited by this paper
• Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism.

  2003cited by this paper
• Current practice regarding the use of fatty livers: A Trans‐Atlantic survey

  2002cited by this paper
• Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat.

  2002cited by this paper
• Postreperfusion biopsies are useful in predicting complications after liver transplantation

  2001influential reference
• Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation

  2001cited by this paper
• Body mass index as a predictor of hepatic steatosis in living liver donors

  2001cited by this paper
• The effect of graded steatosis on flow in the hepatic parenchymal microcirculation.

  1999cited by this paper
• Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation.

  1999influential reference
• Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program.

  1998influential reference
• Multivariate Analysis

  1998cited by this paper
• The mechanism of injury in a steatotic liver graft during cold preservation.

  1998cited by this paper
• Noninvasive in vivo quantitative assessment of fat content in human liver.

  1997cited by this paper
• Use of livers with microvesicular fat safely expands the donor pool.

  1997influential reference
• Liver injury following normothermic ischemia in steatotic rat liver

  1994cited by this paper
• Risk factors for primary dysfunction after liver transplantation--a multivariate analysis.

  1993cited by this paper
• The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation.

  1991cited by this paper
• The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation.

  1991cited by this paper
• Primary nonfunction of hepatic allografts with preexisting fatty infiltration.

  1989influential reference
• SINUSOIDAL STENOSIS AS THE CAUSE OF PORTAL HYPERTENSION IN CHOLINE DEFICIENT DIET INDUCED FATTY CIRRHOSIS OF THE RAT LIVER

  1974cited by this paper

• A Scoping Review of the Photographic Assessment of Donor Liver Steatosis in Transplantation Using Artificial Intelligence

  2026cites this paper
• Outcomes and risk factors for liver transplantation using steatotic grafts for hepatocellular carcinoma: a multicenter study.

  2025cites this paper
• EASL Clinical Practice Guidelines on TIPS.

  2025cites this paper
• Recipient Toll-like Receptor 4 Determines the Outcome of Ischemia-Reperfusion Injury in Steatotic Liver Transplantation in Mice.

  2025cites this paper
• A novel ASGR1-Targeting nanocomplex for mitigating donor liver steatosis

  2025cites this paper
• Visual assessment of liver steatosis at retrieval predicts long term liver transplant outcomes in donation following circulatory death.

  2025cites this paper
• Steatotic liver disease and liver transplantation: Candidate selection and post-transplant management

  2025cites this paper
• Era of metabolic dysfunction-associated steatotic liver disease and impact on the liver donor pool

  2025cites this paper
• Transplantation of Severely Steatotic Liver Grafts After Machine Perfusion Remains a Risky Challenge

  2025cites this paper
• Current Understanding of Marginal Grafts in Liver Transplantation

  2024cites this paper
• Metabolic dysfunction-associated steatotic liver disease throughout the liver transplant cycle: a comprehensive review

  2024cites this paper
• Impact of Resuscitated Cardiac Arrest in the Brain-dead Donors on the Outcome of Liver Transplantation: A Retrospective and Propensity Score Matching Analysis

  2024cites this paper
• The role of Neuregulin-1 in steatotic and non-steatotic liver transplantation from donors after cardiocirculatory death

  2024cites this paper
• Quantification of liver fat using non-invasive MRI-PDFF technique versus guided biopsy in potential liver donor

  2024cites this paper
• Long-term normothermic machine perfusion of fatty livers: towards transplanting untransplantable livers?

  2024cites this paper
• CT-Based Hounsfield Units for Pre-donation Liver Steatosis Assessment: Enhancing Transplant Outcomes and Efficiency

  2024cites this paper
• The Potential Utilization of Machine Perfusion to Increase Transplantation of Macrosteatotic Livers

  2024cites this paper
• Steatotic Donor Transplant Livers: Preservation Strategies to Mitigate against Ischaemia-Reperfusion Injury

  2024cites this paper
• Upfront Normothermic Machine Perfusion for a Liver Graft with Severe Macrovesicular Steatosis: A Proof-of-Concept Case

  2023influential citation
• Quantitative MRI of liver grafts for assessment of macrovesicular steatosis ex vivo and long-term follow-up outcomes

  2023cites this paper
• Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy

  2023cites this paper
• Impact of Median MELD at Transplant Minus 3 National Policy on Quality of Transplanted Livers for Patients With and Without Hepatocellular Carcinoma

  2023cites this paper
• How to Preserve Steatotic Liver Grafts for Transplantation

  2023cites this paper
• Improved assessment of donor liver steatosis using Banff consensus recommendations and deep learning algorithms.

  2023cites this paper
• Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome

  2022cites this paper
• Outcome of liver transplantation with grafts from brain‐dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors

  2022cites this paper
• Preoperative portal vein recanalization–transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: Outcomes following liver transplantation

  2022cites this paper
• The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors

  2022cites this paper
• Normothermic Machine Perfusion—Improving the Supply of Transplantable Livers for High-Risk Recipients

  2022cites this paper
• Small-For-Size Syndrome and Graft Inflow Modulation Techniques in Liver Transplantation

  2022cites this paper
• A Novel Digital Algorithm for Identifying Liver Steatosis Using Smartphone-Captured Images

  2022cites this paper
• Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion

  2022influential citation
• Gamma-glutamyltransferase predicts macrovesicular liver graft steatosis – an analysis of discarded liver allografts in Finland

  2022cites this paper
• Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation

  2021cites this paper
• A proof of concept study on real-time LiMAx CYP1A2 liver function assessment of donor grafts during normothermic machine perfusion

  2021cites this paper
• Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient survival.

  2021cites this paper
• Expanding Role of Donation After Circulatory Death Donors in Liver Transplantation.

  2021cites this paper
• Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes From a Multicenter Cohort

  2021cites this paper
• Intraoperative Evaluation of the Liver, Extrahepatic Bile Ducts, Gallbladder, and Pancreas

  2021cites this paper
• Magnetic resonance imaging‐derived proton density fat fraction (MRI‐PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantation

  2021cites this paper
• Primary Nonfunction of the Liver Allograft

  2021cites this paper
• Post–Liver Transplant Early Allograft Dysfunction Modifies the Effect of Pre–Liver Transplant Renal Dysfunction on Post–Liver Transplant Survival

  2021cites this paper
• Perioperative and long‐term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis

  2020cites this paper
• Ischemic Cholangiopathy

  2020cites this paper
• A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis

  2020cites this paper
• Donor Selection in DCD Liver Transplantation

  2020cites this paper
• Graft factors as determinants of postoperative delirium after liver transplantation

  2020cites this paper
• Sequential Protocol Biopsies Post–Liver Transplant From Donors With Moderate Macrosteatosis: What Happens to the Fat?

  2020cites this paper
• The Changing Landscapes in DCD Liver Transplantation

  2020cites this paper
• Donation after Circulatory Death (DCD) Liver Transplantation: A Practical Guide

  2020cites this paper
• Clear mortality gap caused by graft macrosteatosis in Chinese patients after cadaveric liver transplantation.

  2020cites this paper
• Response to “Macrosteatosis is a huge problem in liver transplantation – however, not the only one we face”

  2019cites this paper
• Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity‐Matched Cohort

  2019cites this paper